MSK
Search
- Page Path
- HOME > Search
Research Support, Non-U.S. Gov't
- In Vivo Studies with a Candida tropicalis Isolate Exhibiting Paradoxical Growth In Vitro in the Presence of High Concentration of Caspofungin
- Sedigh Bayegan , Laszlo Majoros , Gabor Kardos , Adam Kemény-Beke , Cecilia Miszti , Renato Kovacs , Rudolf Gesztelyi
- J. Microbiol. 2010;48(2):170-173. Published online May 1, 2010
- DOI: https://doi.org/10.1007/s12275-010-9221-y
- 58 View
- 0 Download
- 18 Crossref
-
Abstract
- We investigated the activity of caspofungin against a Candida tropicalis clinical isolate showing paradoxical growth in vitro. BALB/c mice immunosuppressed by cyclophosphamide were infected intraperitoneally using 107 CFU/mouse. Caspofungin was administered intraperitoneally once daily for 5 days or as a single dose using the following doses: 0.12, 0.25, 1, 2, 3, 5, and 15 mg/kg. The single dose of caspofungin was effective only at 5 and 15 mg/kg concentrations (100% survival). Five-day caspofungin treatment led to 100% survival at doses of 1 mg/kg or higher. Caspofungin treatment significantly decreased the number of viable yeasts in the peritoneal lavage samples as well as in the infected abscesses at doses 1, 3, 5, and 15 mg/kg caspofungin as compared to the untreated control (P<0.001 in all cases), and even to the group treated with 0.12 mg/kg caspofungin (P<0.05 in all cases). At 2 mg/kg caspofungin dose, sterilization of the internal organs was reproducibly incomplete, suggesting that the role of paradoxical growth in the late clinical failure cannot be excluded.
-
Citations
Citations to this article as recorded by
- Adaptation of the emerging pathogenic yeast Candida auris to high caspofungin concentrations correlates with cell wall changes
Violeta Lara-Aguilar, Cristina Rueda, Irene García-Barbazán, Sarai Varona, Sara Monzón, Pilar Jiménez, Isabel Cuesta, Ángel Zaballos, Óscar Zaragoza
Virulence.2021; 12(1): 1400. CrossRef - Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species
Zoltán Tóth, Lajos Forgács, Tamás Kardos, Renátó Kovács, Jeffrey B. Locke, Gábor Kardos, Fruzsina Nagy, Andrew M. Borman, Awid Adnan, László Majoros
Journal of Fungi.2020; 6(3): 136. CrossRef - Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance
Ulrike Binder, Maria Aigner, Brigitte Risslegger, Caroline Hörtnagl, Cornelia Lass-Flörl, Michaela Lackner
Journal of Fungi.2019; 5(3): 83. CrossRef - Treatment of Invasive Candidiasis: A Narrative Review
Ronen Ben-Ami
Journal of Fungi.2018; 4(3): 97. CrossRef - Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxis
E W Muilwijk, J A Maertens, W J F M van der Velden, R ter Heine, A Colbers, D M Burger, D Andes, K Theunissen, N M A Blijlevens, R J M Brüggemann
Journal of Antimicrobial Chemotherapy.2018; 73(11): 3095. CrossRef - An Update on Candida tropicalis Based on Basic and Clinical Approaches
Diana L. Zuza-Alves, Walicyranison P. Silva-Rocha, Guilherme M. Chaves
Frontiers in Microbiology.2017;[Epub] CrossRef - Recent Insights into the Paradoxical Effect of Echinocandins
Johannes Wagener, Veronika Loiko
Journal of Fungi.2017; 4(1): 5. CrossRef - Drug resistance mechanisms and their regulation in non-albicans Candidaspecies
Anna Kołaczkowska, Marcin Kołaczkowski
Journal of Antimicrobial Chemotherapy.2016; 71(6): 1438. CrossRef - The Eagle-Like Effect of the Echinocandins: Is It Relevant for Clinical Decisions?
Kayla R. Stover, John D. Cleary
Current Fungal Infection Reports.2015; 9(2): 88. CrossRef - Paradoxical Growth of Candida albicans in the Presence of Caspofungin Is Associated with Multiple Cell Wall Rearrangements and Decreased Virulence
Cristina Rueda, Manuel Cuenca-Estrella, Oscar Zaragoza
Antimicrobial Agents and Chemotherapy.2014; 58(2): 1071. CrossRef - The Eagle-like effect of echinocandins: what’s in a name?
Kim Vanstraelen, Katrien Lagrou, Johan Maertens, Joost Wauters, Ludo Willems, Isabel Spriet
Expert Review of Anti-infective Therapy.2013; 11(11): 1179. CrossRef -
The Postantifungal and Paradoxical Effects of Echinocandins Against
Candida
spp.
Brad Moriyama, Stacey A Henning, Scott R Penzak, Thomas J Walsh
Future Microbiology.2012; 7(5): 565. CrossRef - Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches
Nicholas D Beyda, Russell E Lewis, Kevin W Garey
Annals of Pharmacotherapy.2012; 46(7-8): 1086. CrossRef - The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
Russell E. Lewis, Pierluigi Viale, Dimitrios P Kontoyiannis
Virulence.2012; 3(4): 368. CrossRef - Candida glabrata, Candida parapsilosisandCandida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance
Sónia Silva, Melyssa Negri, Mariana Henriques, Rosário Oliveira, David W. Williams, Joana Azeredo
FEMS Microbiology Reviews.2012; 36(2): 288. CrossRef - Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin againstCandida speciesusing time-kill methodology
Judit Szilágyi, Richárd Földi, Sedigh Bayegan, Gábor Kardos, László Majoros
Journal of Chemotherapy.2012; 24(1): 18. CrossRef - Echinocandins: Are They All The Same?
PK Mukherjee, D Sheehan, L Puzniak, H Schlamm, MA Ghannoum
Journal of Chemotherapy.2011; 23(6): 319. CrossRef - Paradoxical Effect of Caspofungin against Candida Bloodstream Isolates Is Mediated by Multiple Pathways but Eliminated in Human Serum
Ryan K. Shields, M. Hong Nguyen, Chen Du, Ellen Press, Shaoji Cheng, Cornelius J. Clancy
Antimicrobial Agents and Chemotherapy.2011; 55(6): 2641. CrossRef
- Adaptation of the emerging pathogenic yeast Candida auris to high caspofungin concentrations correlates with cell wall changes
First
Prev
TOP
